Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joel S. Kanter currently holds 35,000 shares of MEDGENICS, INC. (MDGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joel S. Kanter has been a net seller of MDGN stock. They have purchased $237.0K and sold $2.9M worth of shares.
Joel S. Kanter's most recent insider trade was on Jan 1, 2021, when they purchased 17,500 shares at $0.00 per share.
Joel S. Kanter serves as Executive at MEDGENICS, INC. (MDGN). They have executed 77 insider transactions totaling $3.1M over their tenure at the company.
Joel S. Kanter holds the position of Executive at MEDGENICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Joel S. Kanter has shown a selling trading pattern, with $237.0K in total purchases and $2.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Joel S. Kanter was on Nov 18, 2009, when they sold $529.9K worth of IFLO shares. This transaction involved 41,893 shares at $12.65 per share.
Joel S. Kanter currently owns 35,000 shares of MEDGENICS, INC. (MDGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joel S. Kanter's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joel S. Kanter has 77 Form 4 filings on record as an insider at MEDGENICS, INC..
Set alerts for Joel S. Kanter and 40,000+ other insiders.